[Search]
[by date] [by subject] [by continent]

IMMUNOLOGY AND IMMUNOTHERAPY OF METASTASIS

Cambridge Symposia , Granlibakken Resort, Lake Tahoe, California
May 9, 1996 - May 15, 1996

Program:
IMMUNOLOGY AND IMMUNOTHERAPY OF METASTASIS-CS896
Organizer: Emilio Barber -Guillem-Hipple Cancer Rsch Ctr
May 9-15, 1996; Lake Tahoe, California

Thur. 5/9-Registration-Orientation

Fri. 5/10-MACROPHAGES IN METASTASIS: TUMOR INFILTRATING MACROPHAGES;
ACTIVITY OF MACROPHAGES AGAINST METASTASIS: G. Heuff, Free Univ
Hosp-Amsterdam, "Macrophage Populations in Different Stages of Induced Hepatic Metastases in
Rats"; F. Miller, Karmanos Cancer Inst, "Immune Mechanisms in the Sequential Steps of
Metastasis"; L. Eisenbach, Weizmann Inst Sci, "Immunotherapy of Tumor Metastasis via Gene
Therapy"-POSTER SESSION 1-NK CELLS IN METASTASIS: T. Whiteside , Pittsburgh
Cancer Inst, "Immunotherapy o f Liver Metastasis with Interleukin 2-Activated Natural Killer Cells";
R. Herberman, Univ Pittsburgh Cancer Inst; Speaker to be Announced

Sat. 5/11-TIL: HETEROGENEITY AND PROGNOSTIC SIGNIFICANCE I: M.N. Burnier ,
Armed Forces Inst Pathology, "Infiltrating Lymphocytes in Uveal Malignant Melanoma"; Speakers
to be Announced-POSTER SESSION 2-TIL: HETEROGENEITY AND PROGNOSTIC
SIGNIFICANCE II: R. Wang , Chiba Univ, "Limited T Cell-Infiltrating Lymphocyte Promoting
Experimental Lung Metastasis"; E. Barber -Guillem, Hipple Cancer Rsch Ctr, "IL-2R Expression in
Solid Tumor Cells"; T. Whiteside , Univ Pittsburgh Sch Med, "Anti-Tumor Effector Cell s:
Extravasation and Control of Metastasis"

Sun. 5/12-IMMUNOTHERAPY OF METASTASIS: Speaker to be Announced; J. Kirkwood ,
Univ Pittsburgh Sch Med, "Monoclonal Antibodies against Melanoma"; V. Schirrmacher, German
Cancer Rsch Ctr, "Strategies for Using Immune T-Cells for Immunotherapy of Metastases "; D.
Berd , Thomas Jefferson Univ, "Autologous Melanoma Vaccine: Relevance to Immunologic
Regression and Immunotherapy"-POSTER SESSION 3-PLENARY AND SPEAKERS TO BE
ANNOUNCED

Mon. 5/13-GENE THERAPY APPROACHES FOR METASTASIS I: Speaker to be
Announced; Speaker to be Announced; S. Eccles, Inst Cancer Rsch, "Therapeutic Applications of
Monoclonal Antibodies Directed against Growth Factor Receptors"; M. Blaese , Nat'l Inst Hlth,
"Genetic Modification of Tumor Cells to Stimulate Host Cell Response and Tumor
Immunity"-POSTER SESSION 4-GENE THERAPY APPROACHES FOR METASTASIS II: L.Eisenbach, Weizmann Inst Science, "Isolation of Tumor Associated Antigen Peptides and their Use
in Imm unotherapy"; K. Hellstrom, Bristol Myers Squibb, "On the Role of Co-Stimulation in Tumor
Immunity"; I. Hart, Rayne Inst, "In vitro and in vivo Transcriptional Targeting of Gene Expression to
Tumor Cells"; Philip Thorpe, Univ Texas SW Med Ctr, "Vascular Ta rgeting-A New Approach to
the Therapy of Solid Tumors"

Tue. 5/14-GENE THERAPY APPROACHES FOR METASTASIS III: B. Mueller, Scripps Rsch
Inst, "Overexpression of Protease Inhibitors as a Strategy for Anti-Metastatic Therapy"; M. Blaese ,
National Institutes Health, "Transfer of the Bacterial Gene for a Negative Selection System or
Suicide Vector for Potential use in Gene Transfer Therapies"; J. Moscat, Univ Autonoma-Canto
Blanco, "Molecular Control Stromelysin Expression, Early Event in Metastasis"-DISCUSSION:
Speakers to be Announced-Banquet (Please note: The re are NO POSTERS on banquet day.)

Wed. 5/15-Departure

Registration :
Cambridge Symposia
1037 Chestnut Street
Newton Upper Falls, MA 02164

Phone:(617)630-1399
Fax:(617)630-1395





Deadline for Abstracts: January 10, 1996

Email for Requests and Registration: symposia@cambridge.org


Posted by: James W. Larkin Host: chi.xensei.com date: January 05, 96 8:54:19
Generated by meetings and positions 1.0 by Kai Garlipp